tetR Antibody

What is tetR protein and how does it function in bacterial systems?

TetR (Tetracycline Repressor) protein regulates transcription of tetracycline resistance determinants in Gram-negative bacteria. In the absence of tetracycline molecules, TetR binds to the DNA-binding domain (tetracycline-resistance determinant site), preventing expression of the efflux pump. When tetracycline molecules are present, they bind to TetR, causing the TetR-tetracycline complex to dissociate from the DNA-binding domain, allowing expression of the efflux pump that transfers tetracycline molecules out of the bacterial cell .

The TetR protein has a well-defined structure consisting of 10 α-helices divided into two functional domains: a DNA-binding domain (α1 to α4) and a ligand-binding domain (α5 to α10) . The binding pocket is a tunnel-like cavity constructed by α5, α6, α7, and α8 helices, which forms the interaction site for tetracycline molecules .

What are the major classes of tetR antibodies available for research applications?

Researchers can choose from several types of tetR antibodies:

• Polyclonal antibodies: Typically raised in rabbits against specific epitopes of tetR protein, offering broad epitope recognition

• Monoclonal antibodies: Available as single antibodies or optimized mixes of epitope-specific antibodies, providing consistent recognition of specific epitopes

• Recombinant monoclonal antibodies: Produced recombinantly (animal-free) for high batch-to-batch consistency and improved sensitivity

Different formats are available for specific applications:

• Non-conjugated antibodies for standard applications

• Conjugated antibodies (HRP, biotin, FITC) for specialized detection methods

How should researchers select the appropriate tetR antibody for their specific experimental applications?

Selection criteria should include:

• Application compatibility: Verify antibody suitability for your intended application (WB, ELISA, ICC/IF)

• Species reactivity: Most tetR antibodies react with Escherichia coli, but some have reactivity against yeast or other species

• Antibody format: Consider whether you need unconjugated or conjugated (HRP, biotin, FITC) antibodies

• Detection sensitivity: Different antibodies have varying detection limits (e.g., 0.2-50 pg for ELISA, 0.8-5 ng for Western blot)

• Targeted tetR variant: Ensure the antibody recognizes your specific tetR variant (TetR-A, B, C, D, or E)

For optimal results in challenging applications, monoclonal antibodies typically offer higher specificity, while polyclonal antibodies may provide better signal amplification .

What are the molecular mechanisms behind tetR binding specificity and how does this inform experimental design?

The binding specificity of tetR is determined by its interaction with tetracycline drugs through its binding pocket. Molecular docking studies show that:

Understanding these mechanisms allows researchers to:

• Design experiments that account for differential binding of various tetracyclines

• Consider how mutations in specific amino acids might affect binding properties

• Develop improved detection systems based on tetR's natural binding characteristics

• Interpret experimental results in the context of specific tetR-tetracycline interactions

What are the recommended protocols for using tetR antibodies in Western blot applications?

For optimal Western blot results with tetR antibodies:

• Sample preparation:

  • Use fresh whole cell lysates (30 μg protein is recommended)

  • Separate proteins using 12% SDS-PAGE gels

• Antibody dilutions:

  • Primary antibody: 1:1000 to 1:10000 dilution is typically recommended

  • Secondary antibody: HRP-conjugated anti-rabbit or anti-mouse IgG at 1:10000 dilution

• Detection:

  • Western blot detection limits range from 0.8-5 ng depending on the antibody

  • Expected band size for TetR(B) is approximately 23.4 kDa, though dimers may appear at higher molecular weights

• Controls:

  • Use non-transfected (-) and transfected (+) cell extracts as negative and positive controls

  • Consider purified recombinant TetR protein as an additional positive control

How can tetR antibodies be effectively used for immunofluorescence studies?

For successful immunofluorescence with tetR antibodies:

• Sample preparation:

  • Fix cells in 4% paraformaldehyde/PBS for 20 minutes

  • Permeabilize with 0.1-1% Triton X-100/PBS for 15 minutes

  • Block with 5% PBS for 45 minutes at room temperature

• Antibody incubation:

  • Primary antibody: Use at 2 μg/ml or a 1:50 dilution

  • Secondary antibody: Fluorophore-conjugated antibodies such as Alexa Fluor® 488

• Important considerations:

  • TetR antibodies are suitable for immunofluorescence studies using cells but may not work for tissues and tissue slices (IHC)

  • Optimize antibody concentration and incubation time for your specific cell type

  • Include appropriate controls, such as cells not expressing tetR protein

• Expected results:

  • In cells expressing tetR or tetR fusion proteins, signal will primarily localize to the nucleus or according to the localization pattern of your fusion protein

What are the binding pocket characteristics of tetR and how do mutations affect drug binding?

The tetR binding pocket has specific structural characteristics that determine its interaction with tetracycline drugs:

• Binding pocket structure:

  • Tunnel-like cavity formed by α5, α6, α7, and α8 helices

  • Contains specific amino acids that form direct contacts with tetracycline molecules

• Key amino acids:

  • Molecular docking studies identified HIS139 as a critical amino acid in the binding pocket

  • Mutation of HIS139 to THR produced a mutant with improved binding characteristics for certain tetracyclines

• Effect of mutations:

  • Site-directed mutagenesis can alter binding specificity and affinity

  • Virtual mutation studies can predict how amino acid substitutions might affect binding properties

  • Saturated virtual mutation can identify optimal mutagenesis sites for improving binding characteristics

• Applications of mutagenesis:

  • Improved detection sensitivity in fluorescence polarization assays

  • Development of tetR variants with altered specificity profiles

  • Creation of tetR mutants with enhanced binding to specific tetracycline derivatives

How do different tetracycline derivatives interact with tetR proteins, and what implications does this have for detection systems?

Different tetracycline derivatives show varying binding characteristics with tetR proteins:

• Binding affinity variations:

  • Surface Plasmon Resonance (SPR) studies demonstrate different association constants (Ka), dissociation constants (Kd), and equilibrium dissociation constants (KD) for various tetracycline derivatives

  • Absolute affinity constants (KA) can be calculated to compare binding affinities across different tetracyclines

• Structural determinants of binding:

  • Molecular docking reveals specific binding sites and intermolecular forces for each tetracycline derivative

  • Total binding energies differ among tetracycline derivatives, with some showing stronger binding than others

• Implications for detection systems:

  • Fluorescence polarization assays can be developed based on tetR-tetracycline binding characteristics

  • Detection sensitivity varies for different tetracycline derivatives based on their binding affinity

  • TetR-based detection methods are comparable to or better than antibody-based immunoassays for tetracyclines

  • TetR production is simpler, more rapid, and less costly than antibody production

How can researchers identify and characterize the specific identity of tetR proteins?

To identify and characterize tetR proteins, researchers can employ several techniques:

• LC-ESI-MS/MS analysis:

  • Can identify unique peptides of the tetR family

  • Allows determination of amino acid sequences, molecular weights, and mass spectrometry results

  • Helps confirm identity by comparing with database entries (e.g., Uniprot Homo Database)

• SDS-PAGE and Western blotting:

  • Verify protein size (approximately 23.4 kDa for TetR(B))

  • Detect expression using specific anti-tetR antibodies

• Structural analysis:

  • Compare amino acid sequence with known tetR proteins (e.g., PDB ID: 4AC0)

  • Identify conserved and variable amino acids to determine tetR variant

• Activity-based characterization:

  • Photoaffinity labeled activity-based protein profiling can identify natural tetR proteins

  • Binding studies with tetracycline derivatives can provide functional characterization

What role do TET proteins play in immune cell function and disease development?

While distinct from bacterial tetR proteins, mammalian TET (Ten-Eleven Translocation) proteins also play important regulatory roles:

• Function in gene regulation:

  • TET proteins regulate gene expression by influencing chromosome structure

  • They modify the chemical structure of DNA by altering methyl groups attached to C, one of the four DNA bases

  • This "epigenetic regulation" by altering DNA accessibility is a major strategy cells use to switch genes on and off

• Importance in immune cells:

  • TET proteins are critical for proper immune cell function

  • Genetic deletion or mutation of TET2 and TET3 in mouse B cells dampens generation of functional IgG antibodies

  • This decreases the effectiveness of immune responses

• Role in disease development:

  • Mice and humans harboring TET mutations develop B cell malignancies

  • TET proteins are involved in suppressing cancer

  • Loss of TET function promotes oncogenesis by aberrantly silencing critical genes

Understanding these mechanisms provides important context for researchers studying gene regulation systems in both prokaryotic and eukaryotic organisms.

What methodological considerations are important when using tetR antibodies in fluorescence polarization assays for drug detection?

Fluorescence polarization assays based on tetR-tetracycline interactions require specific methodological considerations:

• Assay development:

  • Consider the binding characteristics of your tetR protein variant

  • Engineer tetR mutants with improved binding for your target tetracycline if needed

  • Design appropriate fluorescent probes that don't interfere with binding

• Optimization parameters:

  • Determine optimal tetR protein concentration for maximum signal-to-noise ratio

  • Establish standard curves using purified tetracyclines

  • Validate assay specificity by testing against various tetracycline derivatives

• Sample preparation:

  • Develop appropriate extraction methods for your sample matrix (e.g., milk)

  • Include proper controls to account for matrix effects

• Data analysis:

  • Calculate IC50 values to determine detection sensitivity for different tetracyclines

  • Compare sensitivities across different tetR variants to select optimal detection reagents

• Advantages over traditional methods:

  • TetR-based methods are comparable to or better than antibody-based immunoassays

  • Production of tetR is simpler, more rapid, and less costly than antibody production

What are the critical quality control parameters for tetR antibodies?

To ensure reliable experimental results, researchers should verify the following quality control parameters:

• Antibody validation:

  • Confirm specificity using Western blot against recombinant tetR and cell lysates expressing tetR

  • Verify reactivity with the specific tetR variant of interest (TetR-A, B, C, D, or E)

• Storage and handling:

  • Store at recommended temperatures (typically -20°C long term)

  • Avoid repeated freeze/thaw cycles

  • Follow manufacturer's buffer recommendations (typically PBS with preservatives like 0.02% sodium azide)

• Performance metrics:

  • Detection limits for different applications (e.g., 0.2-50 pg for ELISA, 0.8-5 ng for Western blot)

  • Dilution ranges for different applications

  • Expected band sizes and potential for dimer formation (tetR is prone to form dimers, and disulfide bridges are possible)

• Cross-reactivity:

  • Understand the specific epitope recognized by your antibody

  • Be aware of potential cross-reactivity with related proteins

  • Include appropriate negative controls in experiments